EyePoint Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: EyePoint Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: EyePoint Pharmaceuticals Inc
Rating: 1.60333325
Author: Trendlyne DVM scores

about

EyePoint Inc focuses on developing and commercializing innovative therapeutics for serious retinal diseases. It develops therapies for serious retinal diseases to provide durable treatments that may reduce the frequency of follow-up care. The company...

16.34 0.81 (5.22%)

317.90% Gain from 52W Low

1.4M

XNAS Volume

XNAS 22 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

8.8 / 100

Technically Neutral

55.3 / 100

1Yr Price target upside is 121%

12 analysts

EyePoint Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

EyePoint Pharma Inc Live Stock Price Today, Share Analysis and Chart

EyePoint Inc focuses on developing and commercializing innovative therapeutics for serious retinal diseases. It develops therapies for serious retinal diseases to provide durable treatments that may reduce the frequency of follow-up care. The company...

317.90% Gain from 52W Low

SWOT Analysis

EyePoint Pharma Inc Live Price Chart